| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/07/2005 | US20050147969 Genes associated with mast cell activation |
| 07/07/2005 | US20050147665 Consisting of eicosapentaenoic acid or derivative, vitamin B 12, folic acid, at a maximum daily dose of 5 mg, and vitamin B6, at a maximum daily dose of 20 mg, and optionally at least one antioxidant; treatment of psychiatric disorders; schizophrenia, Alzheimer's disease, dementia, Parkinson's disease |
| 07/07/2005 | US20050147623 Recombinant parainfluenza virus expression systems and vaccines |
| 07/07/2005 | US20050147619 Anion exchange resin adsorbed fraction immunopotentiator and promoter for recovery from loaded stress originating in matsutake mushroom |
| 07/07/2005 | US20050147586 Novel therapeutic processes and useful compositions therefor |
| 07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 07/07/2005 | US20050147565 using inhalants containing aerosol suspensions comprising mometasone furoate, formoterol fumarate and 1,1,1,2,3,3,3,-heptafluoropropane |
| 07/07/2005 | CA2551189A1 Therapeutic agents and uses therefor |
| 07/07/2005 | CA2550843A1 Novel phenylalanine derivatives |
| 07/07/2005 | CA2549485A1 Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection |
| 07/07/2005 | CA2549173A1 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 07/07/2005 | CA2549122A1 Detection of cd20 in therapy of autoimmune diseases |
| 07/07/2005 | CA2549114A1 Immunostimulant composition comprising at least one toll-like 7 receptor or toll-like 8 receptor agonist and a toll-like 4 receptor agonist |
| 07/07/2005 | CA2548452A1 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | CA2548374A1 Pyrazole derivatives as protein kinase modulators |
| 07/07/2005 | CA2546943A1 Novel compounds |
| 07/06/2005 | EP1550729A1 Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain |
| 07/06/2005 | EP1550705A1 Allergen inactivator |
| 07/06/2005 | EP1550662A1 Novel adenine compound and use thereof |
| 07/06/2005 | EP1550660A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/06/2005 | EP1550460A1 Method for correcting immune responses and medicinal agent |
| 07/06/2005 | EP1550459A1 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 07/06/2005 | EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/06/2005 | EP1550449A1 Antitumor agents with the use of hsv |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549746A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 07/06/2005 | EP1549741A1 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549651A1 Kinase inhibitors |
| 07/06/2005 | EP1549648A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 07/06/2005 | EP1549644A1 Azolidinone-vinyl fused-benzene derivatives |
| 07/06/2005 | EP1549640A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/06/2005 | EP1549637A1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549620A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 07/06/2005 | EP1549619A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 07/06/2005 | EP1549598A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| 07/06/2005 | EP1549349A1 Non-viral gene delivery system |
| 07/06/2005 | EP1549347A1 Modulation of immune function |
| 07/06/2005 | EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants |
| 07/06/2005 | EP1549340A1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 07/06/2005 | EP1549335A1 A method of modulating cellular activity and molecules for use therein |
| 07/06/2005 | EP1549322A2 Lipid a and other carbohydrate ligand analogs |
| 07/06/2005 | EP1549319A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 07/06/2005 | EP1549293A1 Accelerating recovery from trauma |
| 07/06/2005 | EP1549198A2 Thymic atrophy |
| 07/06/2005 | EP1490315A4 Controlling chemical reactions by spectral chemistry and spectral conditioning |
| 07/06/2005 | EP1411956B1 Use of oversulfated polysaccharides as inhibitors of hiv |
| 07/06/2005 | EP1373256B1 Ccr5 antagonists useful for treating aids |
| 07/06/2005 | EP1230375B1 Inhibiting gene expression with dsrna |
| 07/06/2005 | CN1636229A Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636063A Genetic vaccine against human immunodeficiency virus |
| 07/06/2005 | CN1636056A Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 07/06/2005 | CN1636015A HCV e1e2 vaccine compositions |
| 07/06/2005 | CN1636014A Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
| 07/06/2005 | CN1636013A DNA vaccines encoding HIV accessory proteins |
| 07/06/2005 | CN1636009A Partial and full agonists of a1 adenosine receptors |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/06/2005 | CN1635913A A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide T |
| 07/06/2005 | CN1635910A Treatment and diagnosis of macrophage mediated disease |
| 07/06/2005 | CN1635908A Antibodies that immunospecifically bind to trail receptors |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635896A Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 07/06/2005 | CN1635886A Method for treating diseases with omega interferon |
| 07/06/2005 | CN1634996A Polyporus albicans polysaccharide, its preparing process and pharmaceutical composition using the compound as active component |
| 07/06/2005 | CN1634987A Spleen polypeptide extract, its preparing process and use |
| 07/06/2005 | CN1634979A Ligand of NKG2D acceptor and use |
| 07/06/2005 | CN1634970A Process for preparing notoginsen triterpenes |
| 07/06/2005 | CN1634582A Crosslinker of anti-FcªŠRIª‡ monoclonal antibody Fab and tripterine |
| 07/06/2005 | CN1634570A Method for preparing interferon long-acting injection microsphere preparation |
| 07/06/2005 | CN1634527A Chinese herbal medicine for treating urticaria |
| 07/06/2005 | CN1634447A Injection of radix ginseng and radix astragali for strengthening healthy energy |
| 07/06/2005 | CN1634409A Medicine capable of reducing blood fat and treating anaphylactic rhinitis and preparation method thereof |
| 07/06/2005 | CN1634372A Technique for improving activity of Job's-tears seed |
| 07/06/2005 | CN1634365A Imunologic function enhancing granule |
| 07/06/2005 | CN1634121A Dripping pills of ganoderma lucidum polysaccharide and polystictus versicolor polysaccharide |
| 07/06/2005 | CN1634063A Externally applied formulation of cetirizine hydrochloride |
| 07/06/2005 | CN1634053A Externally used loratadine formulation |
| 07/06/2005 | CN1634046A Use of rapamycin in preparation of intraocularly embedded drug |
| 07/06/2005 | CN1634036A Andrographolide soft capsule formulation and preparation method thereof |
| 07/06/2005 | CN1634001A Alkannin nano-granule and its preparation method |
| 07/06/2005 | CN1209367C 3-glyeosyl flavone or its derivative and its preparation method and use |
| 07/06/2005 | CN1209358C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/06/2005 | CN1209354C Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/06/2005 | CN1209352C Hydrazine derivatives |
| 07/06/2005 | CN1209351C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR3 receptor antagonists |
| 07/06/2005 | CN1209127C Application of yellowstem milkwort in preparing medicine for treating Meniere's Disease |
| 07/06/2005 | CN1209106C Use of ellagic acid as anti-pollution cosmetic agent |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6914044 Compounds and methods for modulating cell adhesion |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913900 Plasma prekallikrein activation and kallikrein production assay |
| 07/05/2005 | US6913753 Incapacitated whole-cell immunogenic bacterial compositions |